Why the study?
Does selective 11β-HSD1 inhibition prevent structural and functional features of diabetic cardiomyopathy in murine models of diabetes and cultured cardiomyocytes?
Population
Type 1 and type 2 murine models of diabetes and cultured cardiomyocytes
Design
Preclinical
Authors
Loading...
May support 11β-HSD1 inhibition in diabetic cardiomyopathy; leaves open need for clinical trials.
Does selective 11β-HSD1 inhibition prevent structural and functional features of diabetic cardiomyopathy in murine models of diabetes and cultured cardiomyocytes?
Inhibition of 11β-HSD1 ameliorates diabetes-induced cardiomyocyte hypertrophy and cardiac fibrosis through modulation of EGFR activity, suggesting a potential therapeutic strategy for diabetic cardiomyopathy.
Zou et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: